We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

After Win, FDA May Backtrack On More Device Approvals

Law360, New York (April 29, 2013, 9:30 PM EDT) -- Earlier this month, a federal judge backed the U.S. Food and Drug Administration's decision to revoke its marketing clearance for a knee implant more than two years after it had initially granted it, a ruling that attorneys worry may embolden the agency to make similar retractions on other medical devices.

U.S. District Judge Robert Wilkins granted the FDA summary judgment April 10 in a suit brought by ReGen Biologics Inc., after the agency decided to rescind its clearance of ReGen's Menaflex knee implant.

The FDA had cleared the implant for marketing in December 2008, but after the change in administrations, the...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Attached Documents

Related

Sections

Case Information

Case Title

Subscribers Only

Case Number

Subscribers Only

Court

District Of Columbia

Nature of Suit

Other Statutory Actions

Judge

Subscribers Only

Date Filed

May 31, 2011

Law Firms

Government Agencies